Tempus AI slides 5.7% as insider filings and high short interest fuel volatility

TEMTEM

Tempus AI (TEM) fell about 5.7% to $51.92 as traders reacted to fresh insider-trading disclosures and continued pressure tied to prior guidance concerns. Elevated short interest and derivatives positioning are amplifying day-to-day volatility in the stock.

1. What’s moving the stock today

Tempus AI shares were lower in Thursday trading, extending a choppy stretch that has been marked by sensitivity to ownership and trading updates. The latest swing follows recent insider-trading disclosures on the company’s investor-relations SEC filing feed, which has become a key near-term focus for momentum traders watching for incremental supply and sentiment shifts. (investors.tempus.com)

2. Why it matters: sentiment is fragile in a crowded trade

TEM’s setup remains prone to outsized moves because bearish positioning is still substantial. Recent short-interest snapshots show tens of millions of shares sold short and a sizable short-float percentage, meaning incremental negative catalysts—company-specific or technical—can translate into sharper daily declines as liquidity thins and hedging activity rises. (marketbeat.com)

3. Background pressure: guidance hangover and dilution sensitivity

Investors have stayed cautious following earlier communications that highlighted strong growth but also left lingering questions about the pace of profitability and the roadmap to sustained margin improvement. Separately, the company has used capital-markets tools (including employee-equity registration statements and prior convertible-note financing), which can keep the market especially alert to any sign of additional share supply. (investors.tempus.com)

4. What to watch next

Near term, traders will watch for any additional SEC ownership filings, shifts in short-interest reporting, and options-market positioning that could intensify volatility. The next major directional catalyst is likely to be company updates that clarify growth durability in diagnostics and data licensing, plus any commentary that changes expectations for the 2026 financial trajectory. (investors.tempus.com)